Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 15

Results For "President"

2635 News Found

SS Innovations sets world record with longest-distance robotic cardiac telesurgery
Medical Device | June 05, 2026

SS Innovations sets world record with longest-distance robotic cardiac telesurgery

The robotic cardiac procedure between Guyana and India, established a new benchmark in global telesurgery across nearly 20,000 kilometres


Maxivision Eye Hospital appoints Karthikeyan V. as Senior VP – Operations
People | June 04, 2026

Maxivision Eye Hospital appoints Karthikeyan V. as Senior VP – Operations

Veteran healthcare leader to oversee operations across Tamil Nadu and Kerala, driving growth and operational excellence


Dr. Saurabh Lall joins KIMS Hospitals as Chief Operating Officer
People | June 04, 2026

Dr. Saurabh Lall joins KIMS Hospitals as Chief Operating Officer

Dr. Lall brings extensive experience in healthcare operations, business strategy, and hospital management


Novo Nordisk launches Wegovy pill in UAE in first global rollout outside US
News | June 04, 2026

Novo Nordisk launches Wegovy pill in UAE in first global rollout outside US

The move signals a major expansion in access to next-generation weight-loss therapies


FICCI and Lilly launch Bharat Life Sciences Awards to recognise India’s scientific excellence
R&D | June 03, 2026

FICCI and Lilly launch Bharat Life Sciences Awards to recognise India’s scientific excellence

A first-of-its-kind national platform honouring the people and institutions shaping the next chapter of life sciences in India


Servier to acquire Edgewise muscular dystrophy business in $2.65 billion deal
News | June 03, 2026

Servier to acquire Edgewise muscular dystrophy business in $2.65 billion deal

The transaction includes an upfront payment of $1.55 billion, along with up to $1.1 billion in regulatory and commercial milestone payments


FDA okays AstraZeneca’s bladder cancer drug Imfinzi Plus BCG
Drug Approval | June 02, 2026

FDA okays AstraZeneca’s bladder cancer drug Imfinzi Plus BCG

First immunotherapy combination approved in the US for BCG-naïve high-risk NMIBC demonstrates a 32% reduction in the risk of disease recurrence, progression, or death


Moderna and Merck’s mRNA cancer vax combo shows 5-year survival in melanoma trial
Clinical Trials | June 02, 2026

Moderna and Merck’s mRNA cancer vax combo shows 5-year survival in melanoma trial

An exploratory overall survival signal also leaned in favor of the combination, though the companies noted the result remains preliminary


BioNTech and Bristol Myers Squibb drug shows strong early signal in lung cancer trial
Clinical Trials | June 02, 2026

BioNTech and Bristol Myers Squibb drug shows strong early signal in lung cancer trial

The safety profile was described as manageable, though not without notable toxicities


Eli Lilly drug slashes lung cancer recurrence risk by 83% in landmark phase 3 trial
Clinical Trials | June 02, 2026

Eli Lilly drug slashes lung cancer recurrence risk by 83% in landmark phase 3 trial

The trial results are for the pharma powerhouse's RET-targeted therapy Retevmo (selpercatinib)